FdaApplication
ANDA 040209
Identifiers
- fda_app_no: ANDA040209
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 1997-07-07 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRIFLUOPERAZINE HYDROCHLORIDE | TRIFLUOPERAZINE HYDROCHLORIDE | EQ 10MG BASE | TABLET;ORAL |
| TRIFLUOPERAZINE HYDROCHLORIDE | TRIFLUOPERAZINE HYDROCHLORIDE | EQ 5MG BASE | TABLET;ORAL |
| TRIFLUOPERAZINE HYDROCHLORIDE | TRIFLUOPERAZINE HYDROCHLORIDE | EQ 1MG BASE | TABLET;ORAL |
| TRIFLUOPERAZINE HYDROCHLORIDE | TRIFLUOPERAZINE HYDROCHLORIDE | EQ 2MG BASE | TABLET;ORAL |
4 products